HOME     CONTACT     BACK

 
 
 
THE PHARMA REVIEW (JULY - AUGUST 2010)

Counterfeit Medicines: Global Problem Requires a Global Approach

D. Sreedhar, Manthan D Janodia, Virendra S Ligade, Ajay G Pise, N. Udupa

Introduction
Safety, Efficacy and Quality of medicines has been a concern since ages. Falsified medicines have been cited in documents dating back to the fourth century BC, and the problem of counterfeit drugs has persisted since then.1
Counterfeit medicine is defined differently by drug regulatory authorities of the globe. The United States Federal Food, Drug and Cosmetic Act’ defines counterfeit drug as a drug which, or the container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, or device, or any likeness thereof, of a drug manufacturer, processor, packer, or distributor other than the person or persons who in fact manufactured, processed, packed, or distributed such drug and which thereby falsely purports or is represented to be the product of, or to have been packed or distributed by, such other drug manufacturer, processor, packer, or distributor..

 

For full text of this article contact the publisher on info@kppub.com

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email: info@kppub.com / fpc@vsnl.com, Website: http://www.kppub.com

 
 
 

 Copyright 2008. KONGPOSH PUBLICATIONS Pvt. Ltd.